Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Saul Langarica, Ph.D.

Concepts (14)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Saul Langarica's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Saul Langarica has written about over time.
Adipose Tissue, 1 publications between 2024 and 2024, average publication date April 2024. Adult, 1 publications between 2024 and 2024, average publication date April 2024. Aged, 1 publications between 2024 and 2024, average publication date April 2024. Female, 1 publications between 2024 and 2024, average publication date April 2024. Graves Ophthalmopathy, 1 publications between 2024 and 2024, average publication date April 2024. Humans, 1 publications between 2024 and 2024, average publication date April 2024. Male, 1 publications between 2024 and 2024, average publication date April 2024. Middle Aged, 1 publications between 2024 and 2024, average publication date April 2024. Oculomotor Muscles, 1 publications between 2024 and 2024, average publication date April 2024. Orbit, 1 publications between 2024 and 2024, average publication date April 2024. Organ Size, 1 publications between 2024 and 2024, average publication date April 2024. Retrospective Studies, 1 publications between 2024 and 2024, average publication date April 2024. ROC Curve, 1 publications between 2024 and 2024, average publication date April 2024. Tomography, X-Ray Computed, 1 publications between 2024 and 2024, average publication date April 2024.

To see the data from this visualization as text, click here.
Langarica's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (14)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.